MedPath

FASTURTEC

FASTURTEC

Discontinued
DIN Number

02271397

Drug Class

Human

Market Date

N/A

Company
HC

sanofi-aventis canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02271397
AIG Number0149668002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
V03AF07 RASBURICASE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

RASBURICASEActive
Strength: 7.5 MG / VIAL
Monograph: RASBURICASE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.